Finance

Lists
BTMD:NASDAQ
biote Corp
$1.61
+8.78%
(+0.13) 1D
$1.60
-0.62% (-0.0100)
After hours
Closed: Aug 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BTMD...
Open
$1.48
High
$1.62
Low
$1.48
Mkt. cap
57.84M
Avg. vol.
270.70K
Volume
275.36K
P/E ratio
14.47
52-wk high
$3.61
52-wk low
$1.27
EPS
$0.11
Beta
1.64
Shares outstanding
28.68M
No. of employees
223
Open
$1.48
High
$1.62
Low
$1.48
Mkt. cap
57.84M
Avg. vol.
270.70K
Volume
275.36K
P/E ratio
14.47
52-wk high
$3.61
52-wk low
$1.27
EPS
$0.11
Beta
1.64
Shares outstanding
28.68M
No. of employees
223
News stories
From web sources and news partners
About biote Corp
CEO-
Employees223
Founded2012
HeadquartersIrving, Texas, United States
SectorPharmaceutical industry
Websitebiote.com
Analyst ratings
Based on 4 analysts giving stock ratings to BTMD in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BTMD in the last 3 months.
Highest
Current $1.61
$2.50 (+55.28%)
Average
$2.00 (+24.22%)
Lowest
$1.50 (-6.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeff Van Sinderen
B. Riley Securities
Hold
Maintained
$1.50
-6.8%
08/10/2026
Jonna Kim
TD Cowen
Buy
Reiterated
$2.00
+24.2%
08/07/2026
Jailendra Singh
Truist Financial
Buy
Maintained
-
-
08/06/2026
George Kelly
Roth MKM
Buy
Maintained
$2.50
+55.3%
08/06/2026
Les Sulewski
Truist Financial
Buy
Maintained
$4.00
+148.4%
04/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
47.96M
46.41M
44.94M
44.23M
Cost of goods sold
13.54M
14.84M
13.98M
14.71M
Cost of revenue
13.54M
14.84M
13.98M
14.71M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.73M
26.07M
26.56M
27.18M
Operating expense
25.73M
26.07M
26.56M
27.18M
Total operating expenses
39.27M
40.90M
40.54M
41.89M
Operating income
8.69M
5.50M
4.40M
2.34M
Other non operating income
797.00K
-2.00K
-5.00K
-6.00K
EBT including unusual items
8.45M
5.60M
3.34M
-7.13M
EBT excluding unusual items
6.75M
3.03M
2.42M
151.00K
Income tax expense
-765.00K
2.99M
662.00K
296.00K
Effective tax rate
-9.05%
53.29%
19.83%
-4.15%
Other operating expenses
-
-
-
-
Net income
8.19M
1.95M
2.28M
-6.56M
Net profit margin
17.07%
4.21%
5.07%
-14.84%
Earnings per share
0.18
0.07
0.08
0.04
Interest and investment income
-
-
-
-
Interest expense
-2.73M
-2.47M
-1.97M
-2.18M
Net interest expenses
-2.73M
-2.47M
-1.97M
-2.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.44M
6.16M
5.08M
3.10M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps